Labstat Inc. and Universal/Global Laboratory Services (GLS) Enter Partnership to Boost Testing Solutions for Tobacco/Nicotine Industry

Enhanced Analytical Capabilities Offer Comprehensive, Customer-Centric Solutions KITCHENER, ON, Aug. 29, 2023 /PRNewswire/ — Labstat Inc., A Certified Group Company, has entered a strategic partnership with Global Laboratory Services, Inc. (GLS), a subsidiary of Universal Leaf Tobacco Company, Inc. This alliance aligns Labstat’s cutting-edge capabilities with GLS’s comprehensive testing services, enabling both companies to offer tobacco … Read more

VESTECK Scientific Advisory Board members address significant global unmet need

WEST CHESTER, Pa., Aug. 28, 2023 /PRNewswire/ — In response to a significant global unmet need for the “SUTURE-TIGHT”™ catheter, VESTECK, Inc. is expanding the International Scientific Advisory Board. We are honored to have Professor Dainis Krievins, from Latvia, Canadian, Dr. Bao Bui and Australian, Professor Ramon Varcoe join the VESTECK Scientific Advisory Board. VESTECK … Read more

IRA Capital Launches Flagship $500 Million Healthcare Real Estate Fund

IRVINE, Calif., Aug, 12, 2023 /PRNewswire/ — IRA Capital (“IRA”), a leading Southern-California based private equity firm, has announced the launch of IRA Healthcare Real Estate Fund, L.P. (the “Fund”) – a $500 Million closed-end fund focused on the acquisition of medical properties and senior housing assets across the United States.  IRA will be leveraging … Read more

BIOXCEL SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against BioXcel Therapeutics, Inc.

NEW ORLEANS, Aug. 11, 2023 /PRNewswire/ — ClaimsFiler, a FREE shareholder information service, reminds investors that they have until September 5, 2023 to file lead plaintiff applications in a securities class action lawsuit against BioXcel Therapeutics, Inc. (NasdaqCM: BTAI), if they purchased the Company’s securities between December 15, 2021 and June 28, 2023, inclusive (the … Read more

Modified starch market size to grow by USD 2,862.71 million from 2022 to 2027; High demand for corn starch to boost the market growth

NEW YORK, Aug. 11, 2023 /PRNewswire/ — The modified starch market size is expected to grow by USD 2,862.71 million during 2022-2027, progressing at a CAGR of 4.36% as per the latest Technavio market research report. North America is estimated to account for 35% of the global market growth during the forecast period. The demand for modified starch in the … Read more

PhenomeX to Report Second Quarter 2023 Financial Results on August 14, 2023

EMERYVILLE, Calif., Aug. 9, 2023 /PRNewswire/ — PhenomeX Inc. (Nasdaq: CELL), the functional cell biology company, today announced that the Company will be reporting financial results for the second quarter 2023 after market on Monday, August 14, 2023. About PhenomeX Inc. PhenomeX is empowering scientists to leverage the full potential of each cell and drive the … Read more

Kessler Topaz Meltzer & Check, LLP Reminds Investors of BioXcel Therapeutics, Inc. of Deadline in Securities Fraud Class Action Lawsuit

RADNOR, Pa., Aug. 8, 2023 /PRNewswire/ — The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the District of Connecticut against BioXcel Therapeutics, Inc. (“BioXcel”) (NASDAQ: BTAI). The action charges BioXcel with violations of the federal securities … Read more

Herbalife Takes Over the Streets of San Antonio to Host Fit Hour to Inspire People to Live Their Best Lives Through Health and Fitness

Proceeds from the event will benefit the Herbalife Nutrition Foundation SAN ANTONIO, July 29, 2023 /PRNewswire/ — Herbalife, a premier health and wellness company and community, took to Market Street today to host its Fit Hour, a live workout for approximately 5,000 Herbalife distributors from across the United States to encourage people to get up … Read more

Sirnaomics Appoints Dr. Francois Lebel as Senior Vice President for Preclinical and Clinical Development

HONG KONG, Germantown, Md. and SUZHOU, China, July 27, 2023  /PRNewswire/ — Sirnaomics Ltd. (the “Company”, Stock Code: 2257.HK, together with its subsidiaries, the “Group” or “Sirnaomics”), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, today announced that Dr. Francois Lebel, M.D., an experienced biopharmaceutical industry executive, has been appointed as Senior Vice President for preclinical and clinical development of the … Read more

Veeva Pulse révèle que l’engagement médical sur le terrain permet d’augmenter l’adoption des traitements de 1,5 fois

Possibilité d’avoir un impact plus large car 70 % des leaders d’opinion clés n’interagissent qu’avec une seule entreprise biopharmaceutique BARCELONE, Espagne, 26 juillet 2023 /PRNewswire/ — Veeva Systems (NYSE: VEEV) a révélé aujourd’hui les résultats de l’impact de la médecine de terrain sur la pratique clinique dans le rapport Veeva Pulse Field Trends. L’analyse montre que l’éducation sur l’état de … Read more